bf/NASDAQ:PTGX_icon.png

COM:PROTAGONIST-INC

Protagonist Therapeutics Inc.

  • Stock

USD

Last Close

41.65

22/11 21:00

Market Cap

2.04B

Beta: -

Volume Today

1.32M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
20.06M
-
30.93M
54.14%
231K
99.25%
28.63M
12,293.07%
27.36M
4.44%
26.58M
2.84%
60M
125.73%
cost of revenue
3.31M
-
gross profit
20.06M
-
30.93M
54.14%
231K
99.25%
28.63M
12,293.07%
27.36M
4.44%
26.58M
2.84%
56.69M
113.27%
selling and marketing expenses
general and administrative expenses
1.86M
-
2.96M
59.30%
6.96M
134.93%
11.78M
69.21%
13.70M
16.28%
15.75M
14.98%
18.64M
18.34%
27.20M
45.92%
31.74M
16.70%
33.49M
5.52%
selling general and administrative expenses
1.86M
-
2.96M
59.30%
6.96M
134.93%
11.78M
69.21%
13.70M
16.28%
15.75M
14.98%
18.64M
18.34%
27.20M
45.92%
31.74M
16.70%
33.49M
5.52%
research and development expenses
7.46M
-
11.83M
58.61%
25.70M
117.27%
46.18M
79.66%
59.50M
28.83%
65.00M
9.25%
74.51M
14.62%
126.01M
69.12%
126.22M
0.17%
120.16M
4.80%
other expenses
-34K
-
-1K
-
-46K
4,500%
-149K
223.91%
-80K
46.31%
-201K
151.25%
cost and expenses
9.32M
-
14.79M
58.75%
32.67M
120.81%
57.96M
77.43%
73.19M
26.28%
80.75M
10.33%
93.14M
15.35%
153.20M
64.48%
157.95M
3.10%
153.65M
2.72%
operating expenses
9.32M
-
14.79M
58.75%
32.67M
120.81%
57.96M
77.43%
73.19M
26.28%
80.75M
10.33%
93.14M
15.35%
153.20M
64.48%
157.95M
3.10%
153.65M
2.72%
interest expense
169K
-
598K
253.85%
-3.37M
-
ebitda
-7.29M
-
-14.46M
98.35%
-27.95M
93.22%
-37.90M
35.60%
-42.27M
11.54%
-77.71M
83.84%
-63.66M
18.08%
-125.55M
97.21%
-131.37M
4.64%
-90.34M
31.23%
operating income
-9.32M
-
-14.79M
58.75%
-32.67M
120.81%
-37.90M
16.01%
-42.27M
11.54%
-80.52M
90.50%
-64.52M
19.88%
-125.84M
95.06%
-131.37M
4.39%
-93.65M
28.71%
depreciation and amortization
258K
-
247K
4.26%
317K
28.34%
406K
28.08%
527K
29.80%
2.81M
433.59%
854K
69.63%
294K
65.57%
3.37M
1,045.92%
3.31M
1.69%
total other income expenses net
-1.77M
-
-83K
95.31%
-4.75M
5,626.51%
940K
119.78%
2.55M
170.85%
2.64M
3.81%
-329K
112.45%
294K
189.36%
3.98M
1,253.74%
-201K
105.05%
income before tax
-11.07M
-
-14.86M
34.19%
-37.18M
150.22%
-36.96M
0.59%
-39.72M
7.48%
-77.88M
96.05%
-64.84M
16.74%
-125.55M
93.62%
-127.39M
1.47%
-78.95M
38.02%
income tax expense
1.75M
-
64K
96.35%
4.16M
6,400%
-406K
109.76%
-799K
96.80%
-691K
13.52%
1.30M
288.86%
-2.92M
324.06%
-3.98M
36.11%
-14.90M
274.32%
net income
-11.07M
-
-14.86M
34.19%
-37.18M
150.22%
-36.96M
0.59%
-38.92M
5.32%
-77.19M
98.30%
-66.15M
14.30%
-122.63M
85.38%
-123.41M
0.64%
-78.95M
36.02%
weighted average shs out
5.88M
-
5.88M
0%
6.50M
10.48%
17.69M
172.15%
22.36M
26.39%
25.89M
15.78%
34.40M
32.84%
46.32M
34.67%
49.04M
5.87%
56.76M
15.74%
weighted average shs out dil
5.88M
-
5.88M
0%
6.50M
10.48%
17.69M
172.15%
22.36M
26.39%
25.89M
15.78%
34.40M
32.84%
46.32M
34.67%
49.04M
5.87%
56.76M
15.74%
eps
-1.88
-
-2.52
34.04%
-5.72
126.98%
-2.09
63.46%
-1.74
16.75%
-2.98
71.26%
-1.92
35.57%
-2.65
38.02%
-2.52
4.91%
-1.39
44.84%
epsdiluted
-1.88
-
-2.52
34.04%
-5.72
126.98%
-2.09
63.46%
-1.74
16.75%
-2.98
71.26%
-1.92
35.57%
-2.65
38.02%
-2.52
4.91%
-1.39
44.84%

All numbers in USD (except ratios and percentages)